Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wach

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|June 27, 2013
MicroRNA profiles classify papillary renal cell carcinoma subtypesS Wach, E Nolte, A Theil, et al.
World Journal of Urology|February 22, 2012
Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy coresB Walter, T Weiss, F Hofstädter, et al.
International Journal of Cancer|April 2, 2011
Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patientsT Greither, P Würl, L Grochola, et al.
Virchows Archiv : an International Journal of Pathology|July 10, 2016
Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapySimone Bertz, S Wach, H Taubert, et al.
International Journal of Cancer|May 28, 2014
Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patientsB Keck, S Wach, H Taubert, et al.
Oncogenesis|March 2, 2016
Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patientsC G Stoehr, R Stoehr, A Wenners, et al.
Nature Communications|August 21, 2021
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancerC Kalogirou, J Linxweiler, P Schmucker, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|June 27, 2013
MicroRNA profiles classify papillary renal cell carcinoma subtypesS Wach, E Nolte, A Theil, et al.
World Journal of Urology|February 22, 2012
Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy coresB Walter, T Weiss, F Hofstädter, et al.
International Journal of Cancer|April 2, 2011
Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patientsT Greither, P Würl, L Grochola, et al.
Virchows Archiv : an International Journal of Pathology|July 10, 2016
Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapySimone Bertz, S Wach, H Taubert, et al.
International Journal of Cancer|May 28, 2014
Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patientsB Keck, S Wach, H Taubert, et al.
Oncogenesis|March 2, 2016
Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patientsC G Stoehr, R Stoehr, A Wenners, et al.
Nature Communications|August 21, 2021
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancerC Kalogirou, J Linxweiler, P Schmucker, et al.
Pageof 2